Lilly gets US FDA nod for additional doses of Trulicity (dulaglutide) to treat type 2 diabetes Read more
Sanofi impacted by disrupted clinical trials and lagging vaccine development due to COVID-19: GlobalData Read more
To accelerate recovery of pharma ancillary industry, primary focus should be financial relief to players Read more